Rank | Gene Set | Z-score |
---|---|---|
1 | lymphoid progenitor cell differentiation (GO:0002320) | 4.88566594 |
2 | DNA deamination (GO:0045006) | 4.82271012 |
3 | facial nerve structural organization (GO:0021612) | 4.76286933 |
4 | ribosomal small subunit assembly (GO:0000028) | 4.67558811 |
5 | proteasome assembly (GO:0043248) | 4.52459389 |
6 | respiratory chain complex IV assembly (GO:0008535) | 4.51723233 |
7 | GPI anchor biosynthetic process (GO:0006506) | 4.42164634 |
8 | platelet dense granule organization (GO:0060155) | 4.35159195 |
9 | mannosylation (GO:0097502) | 4.23883594 |
10 | ribosomal small subunit biogenesis (GO:0042274) | 4.21645585 |
11 | viral transcription (GO:0019083) | 4.18025070 |
12 | positive regulation of cellular amine metabolic process (GO:0033240) | 4.09217241 |
13 | presynaptic membrane assembly (GO:0097105) | 3.98399232 |
14 | translational termination (GO:0006415) | 3.92980143 |
15 | short-term memory (GO:0007614) | 3.88202967 |
16 | cotranslational protein targeting to membrane (GO:0006613) | 3.82661702 |
17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.82503001 |
18 | GPI anchor metabolic process (GO:0006505) | 3.79937974 |
19 | protein targeting to ER (GO:0045047) | 3.76179604 |
20 | postsynaptic membrane organization (GO:0001941) | 3.67256877 |
21 | C-terminal protein lipidation (GO:0006501) | 3.67070481 |
22 | response to interferon-beta (GO:0035456) | 3.65600588 |
23 | regulation of pigment cell differentiation (GO:0050932) | 3.64781711 |
24 | response to folic acid (GO:0051593) | 3.64467639 |
25 | protein localization to endoplasmic reticulum (GO:0070972) | 3.63728776 |
26 | cytochrome complex assembly (GO:0017004) | 3.60165602 |
27 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.58385785 |
28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.52847528 |
29 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.48642711 |
30 | cranial nerve structural organization (GO:0021604) | 3.45458779 |
31 | protein maturation by protein folding (GO:0022417) | 3.42322942 |
32 | immunoglobulin mediated immune response (GO:0016064) | 3.40643123 |
33 | mature B cell differentiation (GO:0002335) | 3.37583972 |
34 | deoxyribonucleotide catabolic process (GO:0009264) | 3.37373969 |
35 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.34106640 |
36 | pattern specification involved in kidney development (GO:0061004) | 3.30692899 |
37 | pinocytosis (GO:0006907) | 3.30691587 |
38 | deoxyribose phosphate catabolic process (GO:0046386) | 3.30287966 |
39 | presynaptic membrane organization (GO:0097090) | 3.29051742 |
40 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.28205606 |
41 | neutrophil activation involved in immune response (GO:0002283) | 3.25823760 |
42 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.25776727 |
43 | mesonephros development (GO:0001823) | 3.19961610 |
44 | fucose catabolic process (GO:0019317) | 3.16887252 |
45 | L-fucose metabolic process (GO:0042354) | 3.16887252 |
46 | L-fucose catabolic process (GO:0042355) | 3.16887252 |
47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.16709278 |
48 | L-phenylalanine metabolic process (GO:0006558) | 3.16709278 |
49 | ATP synthesis coupled proton transport (GO:0015986) | 3.14618522 |
50 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.14618522 |
51 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.11319116 |
52 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.07726163 |
53 | regulation of mitochondrial translation (GO:0070129) | 3.07303653 |
54 | amino sugar catabolic process (GO:0046348) | 3.06675606 |
55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.06256518 |
56 | cranial nerve morphogenesis (GO:0021602) | 3.05645120 |
57 | respiratory electron transport chain (GO:0022904) | 3.04603592 |
58 | central nervous system myelination (GO:0022010) | 3.04072532 |
59 | axon ensheathment in central nervous system (GO:0032291) | 3.04072532 |
60 | mature B cell differentiation involved in immune response (GO:0002313) | 3.03479853 |
61 | translational elongation (GO:0006414) | 3.03293208 |
62 | cellular response to zinc ion (GO:0071294) | 3.02689748 |
63 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.02398542 |
64 | C-terminal protein amino acid modification (GO:0018410) | 3.01766686 |
65 | nucleotide salvage (GO:0043173) | 3.01321818 |
66 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.98615238 |
67 | electron transport chain (GO:0022900) | 2.97011874 |
68 | viral life cycle (GO:0019058) | 2.96501758 |
69 | maturation of SSU-rRNA (GO:0030490) | 2.96412206 |
70 | endothelium development (GO:0003158) | 2.95264850 |
71 | response to interferon-alpha (GO:0035455) | 2.92408711 |
72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92287165 |
73 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92287165 |
74 | developmental pigmentation (GO:0048066) | 2.91026494 |
75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.89724208 |
76 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.87668255 |
77 | purine nucleotide salvage (GO:0032261) | 2.87452525 |
78 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.87201057 |
79 | N-acetylneuraminate metabolic process (GO:0006054) | 2.86392979 |
80 | negative regulation of metanephros development (GO:0072217) | 2.84298483 |
81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.82995198 |
82 | L-phenylalanine catabolic process (GO:0006559) | 2.82995198 |
83 | phospholipid scrambling (GO:0017121) | 2.81347541 |
84 | heme metabolic process (GO:0042168) | 2.80489036 |
85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79651411 |
86 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.79145668 |
87 | autophagic vacuole fusion (GO:0000046) | 2.77956439 |
88 | cellular protein complex disassembly (GO:0043624) | 2.77650422 |
89 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.75437817 |
90 | GTP biosynthetic process (GO:0006183) | 2.73452100 |
91 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.72801215 |
92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72254970 |
93 | B cell mediated immunity (GO:0019724) | 2.72076134 |
94 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.71126008 |
95 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.70767366 |
96 | termination of RNA polymerase III transcription (GO:0006386) | 2.70195774 |
97 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.70195774 |
98 | androgen biosynthetic process (GO:0006702) | 2.69797645 |
99 | negative regulation of B cell apoptotic process (GO:0002903) | 2.69327224 |
100 | cellular response to interferon-beta (GO:0035458) | 2.69222841 |
101 | negative regulation of myotube differentiation (GO:0010832) | 2.69068983 |
102 | mast cell activation (GO:0045576) | 2.68158423 |
103 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.66409817 |
104 | nephron tubule formation (GO:0072079) | 2.66407326 |
105 | oxidative phosphorylation (GO:0006119) | 2.65889557 |
106 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.64630891 |
107 | regulation of superoxide anion generation (GO:0032928) | 2.64025858 |
108 | DNA ligation (GO:0006266) | 2.63901421 |
109 | pyrimidine nucleoside salvage (GO:0043097) | 2.62945537 |
110 | pyrimidine-containing compound salvage (GO:0008655) | 2.62945537 |
111 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.62719646 |
112 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.62145671 |
113 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.61952061 |
114 | defense response to protozoan (GO:0042832) | 2.61810378 |
115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61667207 |
116 | deoxyribose phosphate metabolic process (GO:0019692) | 2.60764632 |
117 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60689206 |
118 | nucleoside salvage (GO:0043174) | 2.60517637 |
119 | protein heterotetramerization (GO:0051290) | 2.60306402 |
120 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.60241829 |
121 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.59267231 |
122 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.58665868 |
123 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.58665868 |
124 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.58304019 |
125 | thyroid gland development (GO:0030878) | 2.57471363 |
126 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.57438325 |
127 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.56638776 |
128 | NADH dehydrogenase complex assembly (GO:0010257) | 2.56638776 |
129 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.56638776 |
130 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.56036951 |
131 | heme biosynthetic process (GO:0006783) | 2.55968413 |
132 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55325745 |
133 | protein targeting to mitochondrion (GO:0006626) | 2.54752634 |
134 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.54642441 |
135 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.53586006 |
136 | cyclooxygenase pathway (GO:0019371) | 2.53449603 |
137 | response to peptidoglycan (GO:0032494) | 2.53445219 |
138 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.53420855 |
139 | GMP metabolic process (GO:0046037) | 2.51368147 |
140 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.51339542 |
141 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.51339542 |
142 | base-excision repair, AP site formation (GO:0006285) | 2.50510462 |
143 | negative regulation of ligase activity (GO:0051352) | 2.49897897 |
144 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.49897897 |
145 | definitive hemopoiesis (GO:0060216) | 2.49451985 |
146 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.49373504 |
147 | protein complex biogenesis (GO:0070271) | 2.48537889 |
148 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.48265163 |
149 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.48161731 |
150 | ribosomal large subunit biogenesis (GO:0042273) | 2.47011433 |
151 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.46975187 |
152 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.46975187 |
153 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.46975187 |
154 | fucosylation (GO:0036065) | 2.46904472 |
155 | glycolipid biosynthetic process (GO:0009247) | 2.46335307 |
156 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.46155054 |
157 | lipopolysaccharide metabolic process (GO:0008653) | 2.44787368 |
158 | tRNA methylation (GO:0030488) | 2.44065103 |
159 | regulation of developmental pigmentation (GO:0048070) | 2.43442060 |
160 | omega-hydroxylase P450 pathway (GO:0097267) | 2.43201833 |
161 | GDP-mannose metabolic process (GO:0019673) | 2.42976901 |
162 | chaperone-mediated protein transport (GO:0072321) | 2.42380387 |
163 | negative regulation of interleukin-12 production (GO:0032695) | 2.42323367 |
164 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.42309942 |
165 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.39483598 |
166 | doxorubicin metabolic process (GO:0044598) | 2.39345544 |
167 | daunorubicin metabolic process (GO:0044597) | 2.39345544 |
168 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.38893656 |
169 | pentose metabolic process (GO:0019321) | 2.38701317 |
170 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.36575275 |
171 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.36575275 |
172 | NIK/NF-kappaB signaling (GO:0038061) | 2.36433700 |
173 | lipoxygenase pathway (GO:0019372) | 2.36116076 |
174 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34706332 |
175 | response to thyroid hormone (GO:0097066) | 2.32347515 |
176 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.30730832 |
177 | galactose catabolic process (GO:0019388) | 2.29290272 |
178 | regulation of chemokine biosynthetic process (GO:0045073) | 2.28844528 |
179 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.27874881 |
180 | cellular metabolic compound salvage (GO:0043094) | 2.27776813 |
181 | deoxyribonucleotide metabolic process (GO:0009262) | 2.27668648 |
182 | establishment of protein localization to mitochondrion (GO:0072655) | 2.26370590 |
183 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.25886775 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.09110076 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.97227288 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.26023365 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.09778897 |
5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.96879331 |
6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.93782128 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.89179819 |
8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.87964984 |
9 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76096715 |
10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.54017475 |
11 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.52671834 |
12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.45470853 |
13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42815858 |
14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.40576083 |
15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.33436580 |
16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.31736432 |
17 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27701849 |
18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.21635131 |
19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11570570 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09716565 |
21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.08803970 |
22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07885411 |
23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.07556937 |
24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.07533481 |
25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06577154 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04955342 |
27 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.02239187 |
28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99978823 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.93209698 |
30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92549175 |
31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.90903241 |
32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.88687049 |
33 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.88496100 |
34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.84751560 |
35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.78280437 |
36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77844812 |
37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.75219456 |
38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73583038 |
39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.71999971 |
40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.67120026 |
41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66722961 |
42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66405705 |
43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66213370 |
44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.63097877 |
45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.62367005 |
46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59708395 |
47 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.59280525 |
48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58064568 |
49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.56823784 |
50 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.56502491 |
51 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56412503 |
52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54659056 |
53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52648304 |
54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50269871 |
55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49355914 |
56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48876519 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48581908 |
58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48331823 |
59 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46970573 |
60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41142836 |
61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41002782 |
62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39200166 |
63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39063823 |
64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38125361 |
65 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37463741 |
66 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.36994152 |
67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35499468 |
68 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35470823 |
69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35363997 |
70 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.35146323 |
71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34954049 |
72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33532788 |
73 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.32698802 |
74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32507628 |
75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.30715399 |
76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30409742 |
77 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.30381883 |
78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29783282 |
79 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28964216 |
80 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.28399875 |
81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26483773 |
82 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25502467 |
83 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.25181425 |
84 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.25019968 |
85 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.24180431 |
86 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23171568 |
87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23168423 |
88 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.23120919 |
89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22898559 |
90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22611967 |
91 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.22303705 |
92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22157344 |
93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22119973 |
94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21789614 |
95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20882581 |
96 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20837512 |
97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20816640 |
98 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.20160319 |
99 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.19664563 |
100 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19402949 |
101 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18987591 |
102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18585954 |
103 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17700076 |
104 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16277658 |
105 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15103342 |
106 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14230294 |
107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14068707 |
108 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12279996 |
109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12260608 |
110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11822882 |
111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11339204 |
112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10685926 |
113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10586007 |
114 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10385765 |
115 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10134433 |
116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09448106 |
117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08105149 |
118 | P68_20966046_ChIP-Seq_HELA_Human | 1.07591039 |
119 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06833140 |
120 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06698331 |
121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06384935 |
122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06330384 |
123 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06034456 |
124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05440138 |
125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05333480 |
126 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04554674 |
127 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03790207 |
128 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03387220 |
129 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.03201447 |
130 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03034910 |
131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02345116 |
132 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02160560 |
133 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01880604 |
134 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01752189 |
135 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.01670332 |
136 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01564739 |
137 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01429331 |
138 | MAF_26560356_Chip-Seq_TH1_Human | 1.01415624 |
139 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01157112 |
140 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00668095 |
141 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.99454366 |
142 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98831525 |
143 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.98648988 |
144 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98068986 |
145 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97820901 |
146 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97357708 |
147 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97297677 |
148 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96617455 |
149 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93980658 |
150 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93652134 |
151 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93409442 |
152 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.92939708 |
153 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92536053 |
154 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.92115120 |
155 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91334894 |
156 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91240353 |
157 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.90981896 |
158 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.90878519 |
159 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.90447527 |
160 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.89964854 |
161 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89940233 |
162 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89144133 |
163 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.88306628 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 4.92906436 |
2 | MP0009379_abnormal_foot_pigmentation | 4.91791153 |
3 | MP0003136_yellow_coat_color | 4.51657046 |
4 | MP0005409_darkened_coat_color | 4.48111821 |
5 | MP0001188_hyperpigmentation | 4.04788855 |
6 | MP0005058_abnormal_lysosome_morphology | 3.93917079 |
7 | MP0005174_abnormal_tail_pigmentation | 3.52810347 |
8 | MP0006292_abnormal_olfactory_placode | 3.52493633 |
9 | MP0004381_abnormal_hair_follicle | 3.49934471 |
10 | MP0003724_increased_susceptibility_to | 3.22977530 |
11 | MP0009840_abnormal_foam_cell | 3.10822225 |
12 | MP0000015_abnormal_ear_pigmentation | 2.84139429 |
13 | MP0005075_abnormal_melanosome_morpholog | 2.73277470 |
14 | MP0002139_abnormal_hepatobiliary_system | 2.72604019 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.68803458 |
16 | MP0003186_abnormal_redox_activity | 2.67930104 |
17 | MP0001986_abnormal_taste_sensitivity | 2.38201418 |
18 | MP0006082_CNS_inflammation | 2.21327151 |
19 | MP0002095_abnormal_skin_pigmentation | 2.15174995 |
20 | MP0003880_abnormal_central_pattern | 2.13135704 |
21 | MP0003075_altered_response_to | 2.08916373 |
22 | MP0005451_abnormal_body_composition | 2.06137601 |
23 | MP0000372_irregular_coat_pigmentation | 2.04463486 |
24 | MP0006036_abnormal_mitochondrial_physio | 2.00485460 |
25 | MP0009785_altered_susceptibility_to | 1.98236105 |
26 | MP0000343_altered_response_to | 1.96686203 |
27 | MP0001835_abnormal_antigen_presentation | 1.90417124 |
28 | MP0005671_abnormal_response_to | 1.88201006 |
29 | MP0002148_abnormal_hypersensitivity_rea | 1.82263269 |
30 | MP0003172_abnormal_lysosome_physiology | 1.80588621 |
31 | MP0004147_increased_porphyrin_level | 1.72523863 |
32 | MP0005397_hematopoietic_system_phenotyp | 1.68343857 |
33 | MP0001545_abnormal_hematopoietic_system | 1.68343857 |
34 | MP0004142_abnormal_muscle_tone | 1.62553157 |
35 | MP0001533_abnormal_skeleton_physiology | 1.60542234 |
36 | MP0005365_abnormal_bile_salt | 1.59826815 |
37 | MP0005165_increased_susceptibility_to | 1.57882925 |
38 | MP0000685_abnormal_immune_system | 1.57836209 |
39 | MP0005025_abnormal_response_to | 1.57751393 |
40 | MP0002009_preneoplasia | 1.57189333 |
41 | MP0002876_abnormal_thyroid_physiology | 1.54296757 |
42 | MP0002396_abnormal_hematopoietic_system | 1.52901396 |
43 | MP0001845_abnormal_inflammatory_respons | 1.50946127 |
44 | MP0008260_abnormal_autophagy | 1.49427028 |
45 | MP0005360_urolithiasis | 1.49167902 |
46 | MP0009278_abnormal_bone_marrow | 1.45117152 |
47 | MP0000681_abnormal_thyroid_gland | 1.43477590 |
48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39820650 |
49 | MP0000465_gastrointestinal_hemorrhage | 1.39250410 |
50 | MP0005000_abnormal_immune_tolerance | 1.38997462 |
51 | MP0002138_abnormal_hepatobiliary_system | 1.38461140 |
52 | MP0002102_abnormal_ear_morphology | 1.34634045 |
53 | MP0002177_abnormal_outer_ear | 1.33904640 |
54 | MP0000858_altered_metastatic_potential | 1.33551923 |
55 | MP0004145_abnormal_muscle_electrophysio | 1.32413960 |
56 | MP0005670_abnormal_white_adipose | 1.31506041 |
57 | MP0001905_abnormal_dopamine_level | 1.29905965 |
58 | MP0005166_decreased_susceptibility_to | 1.26934714 |
59 | MP0002419_abnormal_innate_immunity | 1.26563865 |
60 | MP0000490_abnormal_crypts_of | 1.25982819 |
61 | MP0002723_abnormal_immune_serum | 1.25372088 |
62 | MP0005319_abnormal_enzyme/_coenzyme | 1.21468681 |
63 | MP0000566_synostosis | 1.18846399 |
64 | MP0002938_white_spotting | 1.17865897 |
65 | MP0005171_absent_coat_pigmentation | 1.17046464 |
66 | MP0000049_abnormal_middle_ear | 1.17030002 |
67 | MP0003938_abnormal_ear_development | 1.15271762 |
68 | MP0003436_decreased_susceptibility_to | 1.13983679 |
69 | MP0001853_heart_inflammation | 1.13516981 |
70 | MP0003763_abnormal_thymus_physiology | 1.13449319 |
71 | MP0001800_abnormal_humoral_immune | 1.12589546 |
72 | MP0005379_endocrine/exocrine_gland_phen | 1.12337238 |
73 | MP0002420_abnormal_adaptive_immunity | 1.12159078 |
74 | MP0002277_abnormal_respiratory_mucosa | 1.11455960 |
75 | MP0009763_increased_sensitivity_to | 1.09746191 |
76 | MP0001819_abnormal_immune_cell | 1.09681091 |
77 | MP0005084_abnormal_gallbladder_morpholo | 1.09537628 |
78 | MP0001764_abnormal_homeostasis | 1.09035884 |
79 | MP0002452_abnormal_antigen_presenting | 1.07474821 |
80 | MP0009333_abnormal_splenocyte_physiolog | 1.05614898 |
81 | MP0000920_abnormal_myelination | 1.03821933 |
82 | MP0001790_abnormal_immune_system | 1.02557313 |
83 | MP0005387_immune_system_phenotype | 1.02557313 |
84 | MP0001542_abnormal_bone_strength | 1.02476759 |
85 | MP0009643_abnormal_urine_homeostasis | 1.01764329 |
86 | MP0006035_abnormal_mitochondrial_morpho | 1.01031978 |
87 | MP0004742_abnormal_vestibular_system | 0.99675783 |
88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99662530 |
89 | MP0005332_abnormal_amino_acid | 0.99431686 |
90 | MP0003195_calcinosis | 0.98530134 |
91 | MP0003656_abnormal_erythrocyte_physiolo | 0.98187873 |
92 | MP0005464_abnormal_platelet_physiology | 0.98112826 |
93 | MP0002638_abnormal_pupillary_reflex | 0.97976344 |
94 | MP0000613_abnormal_salivary_gland | 0.97206460 |
95 | MP0009697_abnormal_copulation | 0.94290948 |
96 | MP0002751_abnormal_autonomic_nervous | 0.94040387 |
97 | MP0000604_amyloidosis | 0.93495872 |
98 | MP0000631_abnormal_neuroendocrine_gland | 0.93128198 |
99 | MP0003011_delayed_dark_adaptation | 0.92412102 |
100 | MP0008058_abnormal_DNA_repair | 0.92225585 |
101 | MP0002166_altered_tumor_susceptibility | 0.90973850 |
102 | MP0003868_abnormal_feces_composition | 0.90864693 |
103 | MP0004019_abnormal_vitamin_homeostasis | 0.90521608 |
104 | MP0004510_myositis | 0.90413102 |
105 | MP0003448_altered_tumor_morphology | 0.90033418 |
106 | MP0006276_abnormal_autonomic_nervous | 0.89524158 |
107 | MP0005085_abnormal_gallbladder_physiolo | 0.88899483 |
108 | MP0002249_abnormal_larynx_morphology | 0.88258447 |
109 | MP0000358_abnormal_cell_content/ | 0.87169521 |
110 | MP0002254_reproductive_system_inflammat | 0.87014949 |
111 | MP0000716_abnormal_immune_system | 0.85927427 |
112 | MP0000609_abnormal_liver_physiology | 0.84190963 |
113 | MP0003866_abnormal_defecation | 0.84189369 |
114 | MP0002398_abnormal_bone_marrow | 0.83221971 |
115 | MP0003638_abnormal_response/metabolism_ | 0.83218322 |
116 | MP0008873_increased_physiological_sensi | 0.82495104 |
117 | MP0001963_abnormal_hearing_physiology | 0.81812462 |
118 | MP0002132_abnormal_respiratory_system | 0.80932578 |
119 | MP0005390_skeleton_phenotype | 0.80632914 |
120 | MP0004947_skin_inflammation | 0.80348215 |
121 | MP0000026_abnormal_inner_ear | 0.80283927 |
122 | MP0002933_joint_inflammation | 0.80168607 |
123 | MP0002998_abnormal_bone_remodeling | 0.79705216 |
124 | MP0001663_abnormal_digestive_system | 0.78877044 |
125 | MP0001881_abnormal_mammary_gland | 0.78874365 |
126 | MP0005023_abnormal_wound_healing | 0.78355912 |
127 | MP0002006_tumorigenesis | 0.78140472 |
128 | MP0010155_abnormal_intestine_physiology | 0.77917616 |
129 | MP0009765_abnormal_xenobiotic_induced | 0.77555344 |
130 | MP0003879_abnormal_hair_cell | 0.77545770 |
131 | MP0000689_abnormal_spleen_morphology | 0.77178699 |
132 | MP0001486_abnormal_startle_reflex | 0.77105941 |
133 | MP0003303_peritoneal_inflammation | 0.76973675 |
134 | MP0005410_abnormal_fertilization | 0.76906051 |
135 | MP0005636_abnormal_mineral_homeostasis | 0.76898879 |
136 | MP0005164_abnormal_response_to | 0.76816642 |
137 | MP0008469_abnormal_protein_level | 0.75812258 |
138 | MP0002272_abnormal_nervous_system | 0.75391798 |
139 | MP0001873_stomach_inflammation | 0.70317650 |
140 | MP0002722_abnormal_immune_system | 0.67448226 |
141 | MP0002067_abnormal_sensory_capabilities | 0.67395471 |
142 | MP0002429_abnormal_blood_cell | 0.66186606 |
143 | MP0003828_pulmonary_edema | 0.65417309 |
144 | MP0002405_respiratory_system_inflammati | 0.65295925 |
145 | MP0001968_abnormal_touch/_nociception | 0.64687002 |
146 | MP0003315_abnormal_perineum_morphology | 0.64218906 |
147 | MP0005423_abnormal_somatic_nervous | 0.63669940 |
148 | MP0008569_lethality_at_weaning | 0.63569752 |
149 | MP0009764_decreased_sensitivity_to | 0.63069744 |
150 | MP0003646_muscle_fatigue | 0.62826612 |
151 | MP0001661_extended_life_span | 0.62167172 |
152 | MP0005408_hypopigmentation | 0.61726545 |
153 | MP0004270_analgesia | 0.61416108 |
154 | MP0003718_maternal_effect | 0.60169776 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Type I transferrin isoform profile (HP:0003642) | 5.27900852 |
2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.06722354 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.06722354 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.06722354 |
5 | Nonprogressive disorder (HP:0003680) | 5.04530626 |
6 | Reduced antithrombin III activity (HP:0001976) | 4.87373401 |
7 | Abnormality of the axillary hair (HP:0100134) | 4.24808140 |
8 | Abnormality of secondary sexual hair (HP:0009888) | 4.24808140 |
9 | Hypothermia (HP:0002045) | 4.02483673 |
10 | Systemic lupus erythematosus (HP:0002725) | 4.00498605 |
11 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.68108906 |
12 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.68108906 |
13 | Abnormal protein glycosylation (HP:0012346) | 3.68108906 |
14 | Abnormal glycosylation (HP:0012345) | 3.68108906 |
15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.65816252 |
16 | Abnormal number of erythroid precursors (HP:0012131) | 3.65041772 |
17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.62068150 |
18 | Vacuolated lymphocytes (HP:0001922) | 3.45799439 |
19 | 3-Methylglutaconic aciduria (HP:0003535) | 3.42072399 |
20 | Acute encephalopathy (HP:0006846) | 3.34613208 |
21 | Thyroid-stimulating hormone excess (HP:0002925) | 3.27622306 |
22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.25082428 |
23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.22421585 |
24 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.19457537 |
25 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.18604986 |
26 | Increased cerebral lipofuscin (HP:0011813) | 3.18412651 |
27 | Aplastic anemia (HP:0001915) | 3.16941446 |
28 | Type 2 muscle fiber atrophy (HP:0003554) | 3.15652401 |
29 | Increased hepatocellular lipid droplets (HP:0006565) | 3.08530759 |
30 | Renal Fanconi syndrome (HP:0001994) | 3.03927549 |
31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.02692342 |
32 | Hepatocellular necrosis (HP:0001404) | 2.99048340 |
33 | Dysostosis multiplex (HP:0000943) | 2.92453419 |
34 | Purpura (HP:0000979) | 2.89433192 |
35 | Reticulocytopenia (HP:0001896) | 2.86795341 |
36 | Progressive macrocephaly (HP:0004481) | 2.85877534 |
37 | Prolonged neonatal jaundice (HP:0006579) | 2.82351755 |
38 | Muscle fiber atrophy (HP:0100295) | 2.80121519 |
39 | Severe visual impairment (HP:0001141) | 2.78561091 |
40 | Amyloidosis (HP:0011034) | 2.77999986 |
41 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.72812036 |
42 | Peripheral hypomyelination (HP:0007182) | 2.71001252 |
43 | Hepatosplenomegaly (HP:0001433) | 2.68922809 |
44 | Progressive neurologic deterioration (HP:0002344) | 2.66345211 |
45 | Attenuation of retinal blood vessels (HP:0007843) | 2.59592147 |
46 | Cerebral edema (HP:0002181) | 2.56969500 |
47 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56822278 |
48 | Exertional dyspnea (HP:0002875) | 2.56753023 |
49 | Increased serum ferritin (HP:0003281) | 2.56407130 |
50 | Loss of speech (HP:0002371) | 2.51652367 |
51 | Complement deficiency (HP:0004431) | 2.50685863 |
52 | Parakeratosis (HP:0001036) | 2.48897602 |
53 | Vertebral compression fractures (HP:0002953) | 2.48734465 |
54 | Progressive inability to walk (HP:0002505) | 2.47384363 |
55 | Mitochondrial inheritance (HP:0001427) | 2.45880642 |
56 | Microvesicular hepatic steatosis (HP:0001414) | 2.44747137 |
57 | Hepatic necrosis (HP:0002605) | 2.43510766 |
58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43124120 |
59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43124120 |
60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43124120 |
61 | Mediastinal lymphadenopathy (HP:0100721) | 2.42745924 |
62 | Respiratory failure (HP:0002878) | 2.41214301 |
63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.40552947 |
64 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.40552947 |
65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.40500838 |
66 | Abnormality of complement system (HP:0005339) | 2.39460010 |
67 | Macrocytic anemia (HP:0001972) | 2.38781036 |
68 | Abnormality of magnesium homeostasis (HP:0004921) | 2.38362406 |
69 | Lactic acidosis (HP:0003128) | 2.34505826 |
70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.32094239 |
71 | Patchy hypopigmentation of hair (HP:0011365) | 2.31661617 |
72 | True hermaphroditism (HP:0010459) | 2.26732478 |
73 | Optic disc pallor (HP:0000543) | 2.24917529 |
74 | Recurrent bacterial skin infections (HP:0005406) | 2.23775876 |
75 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23004474 |
76 | Myositis (HP:0100614) | 2.22687869 |
77 | Rough bone trabeculation (HP:0100670) | 2.21080201 |
78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20060977 |
79 | Dry hair (HP:0011359) | 2.19393985 |
80 | Abnormal sex determination (HP:0012244) | 2.17968392 |
81 | Sex reversal (HP:0012245) | 2.17968392 |
82 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17956761 |
83 | Pallor (HP:0000980) | 2.17822783 |
84 | Meningitis (HP:0001287) | 2.16485261 |
85 | Stomatitis (HP:0010280) | 2.16285932 |
86 | Abnormality of iron homeostasis (HP:0011031) | 2.16235036 |
87 | Glomerulonephritis (HP:0000099) | 2.14654247 |
88 | Mucopolysacchariduria (HP:0008155) | 2.14475066 |
89 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14475066 |
90 | Cerebral palsy (HP:0100021) | 2.14044374 |
91 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.12884679 |
92 | Retinal dysplasia (HP:0007973) | 2.12516831 |
93 | Flat occiput (HP:0005469) | 2.11915542 |
94 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.09414381 |
95 | Absent/shortened dynein arms (HP:0200106) | 2.09414381 |
96 | Prolonged partial thromboplastin time (HP:0003645) | 2.08965742 |
97 | Petechiae (HP:0000967) | 2.05582479 |
98 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.05520121 |
99 | Dicarboxylic aciduria (HP:0003215) | 2.03325801 |
100 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03325801 |
101 | Prolonged bleeding time (HP:0003010) | 2.03291145 |
102 | Abnormal ciliary motility (HP:0012262) | 2.03105962 |
103 | Axonal loss (HP:0003447) | 2.02611946 |
104 | White forelock (HP:0002211) | 2.02598591 |
105 | Hyperammonemia (HP:0001987) | 2.02384469 |
106 | Exercise intolerance (HP:0003546) | 2.02171392 |
107 | Recurrent abscess formation (HP:0002722) | 2.01822210 |
108 | Distal lower limb muscle weakness (HP:0009053) | 2.01261495 |
109 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.99966265 |
110 | Generalized aminoaciduria (HP:0002909) | 1.99961214 |
111 | Nausea (HP:0002018) | 1.98741978 |
112 | Hypertensive crisis (HP:0100735) | 1.98347726 |
113 | Thrombocytosis (HP:0001894) | 1.97001931 |
114 | Increased IgM level (HP:0003496) | 1.95998894 |
115 | Microcytic anemia (HP:0001935) | 1.95903962 |
116 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95657404 |
117 | Obstructive lung disease (HP:0006536) | 1.95657404 |
118 | Lethargy (HP:0001254) | 1.95504773 |
119 | IgM deficiency (HP:0002850) | 1.94993747 |
120 | Increased CSF lactate (HP:0002490) | 1.93996722 |
121 | Abnormality of the prostate (HP:0008775) | 1.93988424 |
122 | Pancytopenia (HP:0001876) | 1.93046975 |
123 | Abnormality of renal resorption (HP:0011038) | 1.91761788 |
124 | Nuclear cataract (HP:0100018) | 1.90977588 |
125 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.89606457 |
126 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.89606457 |
127 | Acute necrotizing encephalopathy (HP:0006965) | 1.87496514 |
128 | Agammaglobulinemia (HP:0004432) | 1.85995913 |
129 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85306375 |
130 | Abnormal trabecular bone morphology (HP:0100671) | 1.85020092 |
131 | Skin rash (HP:0000988) | 1.84222384 |
132 | Ulnar claw (HP:0001178) | 1.83851063 |
133 | Weak cry (HP:0001612) | 1.83513522 |
134 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.83306858 |
135 | Hypomagnesemia (HP:0002917) | 1.82797638 |
136 | Abnormality of the columella (HP:0009929) | 1.81960466 |
137 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.80112692 |
138 | Epistaxis (HP:0000421) | 1.79292163 |
139 | Pulmonary infiltrates (HP:0002113) | 1.79011337 |
140 | Beaking of vertebral bodies (HP:0004568) | 1.78717801 |
141 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78597664 |
142 | Eczematoid dermatitis (HP:0000976) | 1.77809497 |
143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76943974 |
144 | Oral leukoplakia (HP:0002745) | 1.76407677 |
145 | Respiratory difficulties (HP:0002880) | 1.76189022 |
146 | CNS demyelination (HP:0007305) | 1.76144318 |
147 | Autoimmune thrombocytopenia (HP:0001973) | 1.75426233 |
148 | Increased muscle lipid content (HP:0009058) | 1.75386498 |
149 | Split foot (HP:0001839) | 1.75271320 |
150 | Hypokinesia (HP:0002375) | 1.74175769 |
151 | Abnormality of macrophages (HP:0004311) | 1.73945690 |
152 | Increased serum lactate (HP:0002151) | 1.73046857 |
153 | Anhidrosis (HP:0000970) | 1.72022091 |
154 | Increased corneal curvature (HP:0100692) | 1.71315666 |
155 | Keratoconus (HP:0000563) | 1.71315666 |
156 | Asplenia (HP:0001746) | 1.70309605 |
157 | Renal tubular dysfunction (HP:0000124) | 1.68956430 |
158 | Gonadal dysgenesis (HP:0000133) | 1.68935404 |
159 | Decreased central vision (HP:0007663) | 1.67132338 |
160 | Cortical visual impairment (HP:0100704) | 1.66583135 |
161 | Pancreatic cysts (HP:0001737) | 1.66283263 |
162 | Retrobulbar optic neuritis (HP:0100654) | 1.64297654 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TNIK | 6.29704107 |
2 | MUSK | 5.41040943 |
3 | VRK2 | 4.14376116 |
4 | CASK | 4.09220475 |
5 | STK16 | 3.58946163 |
6 | TESK2 | 3.45015855 |
7 | MKNK2 | 2.90520436 |
8 | TESK1 | 2.88012961 |
9 | ERN1 | 2.64762262 |
10 | SRPK1 | 2.51816106 |
11 | NME2 | 2.49773445 |
12 | BCKDK | 2.32728577 |
13 | EIF2AK3 | 2.32684208 |
14 | NLK | 2.31114060 |
15 | ABL2 | 2.26716856 |
16 | MAP3K11 | 2.19720121 |
17 | ARAF | 2.08072198 |
18 | CDK19 | 1.95224916 |
19 | MKNK1 | 1.94468800 |
20 | FES | 1.90229420 |
21 | KIT | 1.83340858 |
22 | TEC | 1.78271077 |
23 | IRAK4 | 1.76710985 |
24 | TLK1 | 1.70473532 |
25 | SCYL2 | 1.67016363 |
26 | IRAK3 | 1.62224847 |
27 | MAP3K3 | 1.47137831 |
28 | TYK2 | 1.41817100 |
29 | LIMK1 | 1.41268985 |
30 | EIF2AK2 | 1.37636336 |
31 | TAOK2 | 1.36274888 |
32 | ADRBK2 | 1.35708503 |
33 | BUB1 | 1.35470702 |
34 | BLK | 1.35184772 |
35 | TXK | 1.30412457 |
36 | CAMKK2 | 1.25978067 |
37 | MAP3K12 | 1.25361850 |
38 | MAP2K3 | 1.24517824 |
39 | VRK1 | 1.23746948 |
40 | MAPKAPK5 | 1.21482690 |
41 | PAK4 | 1.16789531 |
42 | BMPR1B | 1.16577671 |
43 | DAPK1 | 1.16014613 |
44 | BTK | 1.15654649 |
45 | MAP2K7 | 1.14492398 |
46 | MAPKAPK3 | 1.14090033 |
47 | PIM2 | 1.12203371 |
48 | IRAK1 | 1.11003454 |
49 | IRAK2 | 1.10997495 |
50 | WEE1 | 1.07951983 |
51 | YES1 | 1.06995117 |
52 | ILK | 1.06166407 |
53 | STK39 | 1.05508085 |
54 | CAMK1 | 1.04012661 |
55 | PDK2 | 1.04002734 |
56 | MAPK15 | 1.03318774 |
57 | EPHA2 | 1.01685712 |
58 | MST1R | 0.99533027 |
59 | GRK7 | 0.98283724 |
60 | GRK1 | 0.97935351 |
61 | CLK1 | 0.93233867 |
62 | OXSR1 | 0.93107057 |
63 | NEK6 | 0.92024118 |
64 | TIE1 | 0.91716654 |
65 | CSNK1G1 | 0.90210054 |
66 | MAP4K2 | 0.89450032 |
67 | IKBKE | 0.88816185 |
68 | JAK3 | 0.85855074 |
69 | MST4 | 0.83752758 |
70 | IKBKB | 0.83468620 |
71 | NEK1 | 0.81172992 |
72 | EIF2AK1 | 0.79186860 |
73 | MAP4K1 | 0.79030588 |
74 | LRRK2 | 0.77007231 |
75 | HIPK2 | 0.76700635 |
76 | PRKG2 | 0.75867440 |
77 | DAPK3 | 0.74438876 |
78 | LYN | 0.73363554 |
79 | MAP3K1 | 0.73076378 |
80 | MAP3K14 | 0.73057331 |
81 | KDR | 0.72182979 |
82 | PIK3CG | 0.71995413 |
83 | MAPK13 | 0.71995323 |
84 | PAK1 | 0.70850780 |
85 | MAP2K6 | 0.70342556 |
86 | TNK2 | 0.68067491 |
87 | FLT3 | 0.67092112 |
88 | CSF1R | 0.65869632 |
89 | GRK6 | 0.64968729 |
90 | MATK | 0.62812402 |
91 | CSNK1G3 | 0.61557356 |
92 | CDK3 | 0.59934390 |
93 | NME1 | 0.59845123 |
94 | SYK | 0.58384285 |
95 | MAPK4 | 0.58066762 |
96 | TGFBR2 | 0.56523528 |
97 | FGR | 0.56457515 |
98 | PRKD2 | 0.56455154 |
99 | MOS | 0.54971668 |
100 | TBK1 | 0.54608831 |
101 | TAOK3 | 0.54173572 |
102 | MYLK | 0.53866234 |
103 | AURKA | 0.53584021 |
104 | LCK | 0.52759328 |
105 | EPHB2 | 0.52266181 |
106 | CAMK2B | 0.51549991 |
107 | RPS6KA5 | 0.48654907 |
108 | GRK5 | 0.47055152 |
109 | DYRK3 | 0.45997743 |
110 | RIPK4 | 0.45953391 |
111 | DYRK2 | 0.45453636 |
112 | BMPR2 | 0.44739843 |
113 | STK10 | 0.43758863 |
114 | LMTK2 | 0.43397130 |
115 | PRPF4B | 0.42034473 |
116 | PRKCD | 0.41663747 |
117 | ITK | 0.40735435 |
118 | MAP3K8 | 0.39066550 |
119 | PHKG1 | 0.38497121 |
120 | PHKG2 | 0.38497121 |
121 | PKN1 | 0.38293780 |
122 | CDK7 | 0.38147670 |
123 | PBK | 0.38137434 |
124 | MAPKAPK2 | 0.37059978 |
125 | CSNK1A1L | 0.36665155 |
126 | UHMK1 | 0.36642296 |
127 | PRKAA2 | 0.36453227 |
128 | BRAF | 0.35959747 |
129 | SMG1 | 0.35792034 |
130 | HCK | 0.33842206 |
131 | MAP3K6 | 0.33069553 |
132 | CAMK2D | 0.32966487 |
133 | PTK2B | 0.31715206 |
134 | CAMK2G | 0.31452157 |
135 | PINK1 | 0.29818042 |
136 | ZAP70 | 0.28660753 |
137 | CSNK2A1 | 0.28264159 |
138 | CSK | 0.28176582 |
139 | PIM1 | 0.27969830 |
140 | ACVR1B | 0.26792739 |
141 | CDK8 | 0.26677706 |
142 | INSRR | 0.25345029 |
143 | PRKG1 | 0.25106818 |
144 | NUAK1 | 0.24853319 |
145 | BRSK2 | 0.24454578 |
146 | BRD4 | 0.23919904 |
147 | CSNK2A2 | 0.23894304 |
148 | CSNK1G2 | 0.22777824 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.50358720 |
2 | Protein export_Homo sapiens_hsa03060 | 3.55464403 |
3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.64705332 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.52861011 |
5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.51183938 |
6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.46341159 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37245011 |
8 | Homologous recombination_Homo sapiens_hsa03440 | 2.25684306 |
9 | RNA polymerase_Homo sapiens_hsa03020 | 2.18712685 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13627984 |
11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.07178988 |
12 | Lysosome_Homo sapiens_hsa04142 | 1.77276934 |
13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75917943 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74885775 |
15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.68969433 |
16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66989580 |
17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.66142766 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60291016 |
19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.56527562 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55713077 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54221717 |
22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.53917757 |
23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50780512 |
24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.42996614 |
25 | Mismatch repair_Homo sapiens_hsa03430 | 1.41924156 |
26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41426244 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41161056 |
28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40500666 |
29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.38283108 |
30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37850997 |
31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.36477179 |
32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34269958 |
33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.30230367 |
34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28409734 |
35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28003722 |
36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27656106 |
37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26750562 |
38 | Purine metabolism_Homo sapiens_hsa00230 | 1.25229187 |
39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23835615 |
40 | Phototransduction_Homo sapiens_hsa04744 | 1.22737266 |
41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22643325 |
42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.22498591 |
43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.22433737 |
44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22032755 |
45 | Allograft rejection_Homo sapiens_hsa05330 | 1.21887182 |
46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21166976 |
47 | Proteasome_Homo sapiens_hsa03050 | 1.20843410 |
48 | Malaria_Homo sapiens_hsa05144 | 1.18391993 |
49 | Base excision repair_Homo sapiens_hsa03410 | 1.16865067 |
50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16791241 |
51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15713326 |
52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12528572 |
53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10996774 |
54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10856718 |
55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09696623 |
56 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09138409 |
57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09132058 |
58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08536649 |
59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08366667 |
60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07699406 |
61 | Asthma_Homo sapiens_hsa05310 | 1.07330012 |
62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04733036 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01219150 |
64 | Spliceosome_Homo sapiens_hsa03040 | 1.00092260 |
65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99305117 |
66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99218036 |
67 | Measles_Homo sapiens_hsa05162 | 0.94255878 |
68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93779070 |
69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93440407 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90492125 |
71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89147440 |
72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89002754 |
73 | Tuberculosis_Homo sapiens_hsa05152 | 0.87933143 |
74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87864835 |
75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87029824 |
76 | Salmonella infection_Homo sapiens_hsa05132 | 0.86936223 |
77 | Phagosome_Homo sapiens_hsa04145 | 0.84815975 |
78 | Shigellosis_Homo sapiens_hsa05131 | 0.84750255 |
79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83295821 |
80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83089787 |
81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82474592 |
82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77799254 |
83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77429408 |
84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77396755 |
85 | RNA degradation_Homo sapiens_hsa03018 | 0.76996672 |
86 | Legionellosis_Homo sapiens_hsa05134 | 0.76772229 |
87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76613360 |
88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76153733 |
89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75253009 |
90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74670528 |
91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74383080 |
92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71873966 |
93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70730859 |
94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69977407 |
95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69823990 |
96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67830167 |
97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67821058 |
98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65939775 |
99 | Pertussis_Homo sapiens_hsa05133 | 0.64546613 |
100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64169655 |
101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63740190 |
102 | ABC transporters_Homo sapiens_hsa02010 | 0.62257109 |
103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60440109 |
104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58274873 |
105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57619840 |
106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57454383 |
107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56742725 |
108 | Nicotine addiction_Homo sapiens_hsa05033 | 0.56596693 |
109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55468787 |
110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53241421 |
111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52297104 |
112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51664446 |
113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51610444 |
114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51212218 |
115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49851307 |
116 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.49037862 |
117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48701525 |
118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47185306 |
119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46507453 |
120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45817727 |
121 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45229841 |
122 | Influenza A_Homo sapiens_hsa05164 | 0.44487758 |
123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43237858 |
124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43230273 |
125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42358678 |
126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42335673 |
127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41727490 |
128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41718748 |
129 | Taste transduction_Homo sapiens_hsa04742 | 0.40641793 |
130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40563524 |
131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40437308 |
132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39414071 |
133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32336638 |
134 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30142327 |
135 | Long-term depression_Homo sapiens_hsa04730 | 0.28413446 |
136 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27611348 |
137 | Peroxisome_Homo sapiens_hsa04146 | 0.26231149 |
138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24360911 |
139 | Morphine addiction_Homo sapiens_hsa05032 | 0.23493717 |
140 | Platelet activation_Homo sapiens_hsa04611 | 0.22819563 |
141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.21981728 |